SemaThera's Seed VC Round

SemaThera raised a round of funding on January 12, 2017. Investors include AmorChem.

SemaThera is a biotechnology company focusing on the development of novel SEMA 3A TRAP inhibitors for the treatment of ocular diseases, such as diabetic macular edema.…

Articles about SemaThera's Seed VC Round: